News

April 1, 2008 - Physio-Control featured its LifePak 12 Defibrillator/Monitor, a multi-parameter device combining semi ...

Home March 31, 2008
Home
News

April 1, 2008 - “Real-world” use of a novel drug-eluting stent coated with a biodegradable polymer is associated with ...

Home March 31, 2008
Home
News

April 1, 2008 – At ACC 2008, Biomedical Systems showcased its Data Exchange, a proprietary Internet-based application ...

Home March 31, 2008
Home
News

April 1, 2008 – Boston Scientific welcomed results from Abbott’s prospective, randomized, single blind, two-year SPIRIT ...

Home March 31, 2008
Home
News

April 1, 2008 — Early results of the SPIRIT II study showed that the XIENCE V sstent was superior to the Taxus stent in ...

Home March 31, 2008
Home
News

April 1, 2008 – Siemens showcased its Artis zee family at the ACC conference this week, its next generation of ...

Home March 31, 2008
Home
News

April 1, 2008 – Boston Scientific announced results from an analysis two-year data from more than 7,000 patients in the ...

Home March 31, 2008
Home
News

March 31, 2008 - New evidence from a large randomized study is answering important questions about the best approach to ...

Home March 30, 2008
Home
News

March 31, 2008 - The direct renin inhibitor aliskiren was found to be as effective as the angiotensin receptor blocker ...

Home March 30, 2008
Home
News

March 31, 2008 – Toshiba featured its AquilionONE at ACC 2008, an advanced diagnostic imaging system that can image an ...

Home March 30, 2008
Home
News

March 31, 2008 – Hitting ACC 2008, the Philips HeartStart Mrx monitor/defibrillator works to enable hospitals to ...

Home March 30, 2008
Home
Technology

The upgraded Philips HeartStart MRx monitor/defibrillator aims to further help the industry realize door-to-balloon guidelines of less than 90 minutes by enabling hospitals to start the clock sooner, organizing their resources, including activating the cath lab, before a STEMI patient arrives.

Home March 30, 2008
Home
News

March 31, 2008 - Over the years, interventional cardiologists have made many improvements in percutaneous coronary intervention (PCI) for patients with heart attack, among the most important, refinements in the selection and administration of drugs that prevent unwanted blood clotting.

Home March 30, 2008
Home
News

April 1, 2008 - Philips at ACC 2008 displayed its cardiovascular IT, the enhanced Xcelera solution, an integrated ...

Home March 30, 2008
Home
News

March 31, 2008 - Although drug-eluting stents have become widely used for the treatment of stable coronary artery ...

Home March 30, 2008
Home
Subscribe Now